Microbot Medical Inc.

NASDAQ:MBOT

Medical - Instruments & Supplies

Healthcare
$0.98 -2.93%

-$0.06 today

Market cap
$65.73M
Beta
1.04
P/E (TTM)
-8.6
EPS (TTM)
-$0.21
52W Low $1.60High $4.67

Volume 0.87M

Average 1.60M

MBOT Investing Cash Flow

Net cash used in or generated by investments in assets, acquisitions, and securities.

Microbot Medical Inc.NASDAQ: MBOT

Investing Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Investing cash flow turns positive

Q1 FY2026 investing cash flow was $5M, compared with -$24.83M a year earlier. Trailing-twelve-month investing cash flow was -$42.56M. Over 3 fiscal years it compounded at +166.2% a year.

Context

  • Investing cash flow increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether quarterly investing cash flow holds near $5M or moves back toward the trailing-twelve-month quarterly average of -$10.64M.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
$5M+426.0% QoQ
Last fiscal yearDec 2025
-$72.38M-4809.4% YoY
LTMMar 2026
-$42.56M+93.4% YoY
Investing Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+120.1%——
1 year-4809.4%——
3-year CAGR+166.2%——
5-year CAGR——
10-year CAGR——

Investing Cash Flow history

USD · from the cash flow

Latest · FY2025
(72.38M) USD
Year-over-year change
-4809.4%

Investing Cash Flow vs competitors

How MBOT compares with its peers on the latest reported figures

  • Peers report in different currencies, so investing cash flow is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of +93.4% is the 5th highest of 10, against a peer median of -86.2%.
  • Investing cash flow amounts to 40530.5% of revenue for MBOT, versus a peer median of 688.1%.
MBOT Competitors
Investing Cash Flow for MBOT and competitors
Company Period LTM YoY 3-year CAGR% of revenue
DCGODocGo Inc.LTM Mar 2026$1.66T USD+11130739.1%+0.5%549888.2%
OVIDOvid Therapeutics Inc.LTM Mar 2026$49.01M USD-224.0%-17.2%688.1%
MBOTMicrobot Medical Inc.LTM Mar 2026$42.56M USD+93.4%+166.2%40530.5%
ORMPOramed Pharmaceuticals Inc.LTM Mar 2026$37.34M USD-137.6%-43.5%—
RCELAVITA Medical, Inc.LTM Mar 2026$3.73M USD-88.7%—5.2%
CNTXContext Therapeutics Inc.LTM Mar 2026$2.04M USD-86.2%+55.9%—
ZTEKZentek Ltd.LTM Mar 2026CA$1.67M CAD+348.1%—1004.2%
VANIVivani Medical, Inc.LTM Mar 2026$1.17M USD+209.0%+51.4%—
CRDLCardiol Therapeutics Inc.LTM Mar 2026CA$60.25K CAD+102.4%-31.1%—
CLNNClene Inc.LTM Mar 2026$39K USD-100.6%-84.3%29.1%
Peer median (excluding MBOT) —-86.2%-17.2%688.1%

Competitors are the stored peer set for MBOT. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(11.31M)(13.17M)(10.74M)(11.44M)(13.14M)
Depreciation & Amortization76K102K106K91K47K
Deferred Income Tax00000
Stock-Based Compensation1.39M1.75M1.39M1.35M1.06M
Change in Working Capital497K(228K)(11K)942K(1.01M)
Accounts Receivables00000
Inventory0000(584K)
Accounts Payables00000
Other Working Capital497K(228K)(11K)942K(424K)
Other Non-Cash Items1.39M(7K)718K234K0
Operating Cash Flow(9.35M)(11.55M)(8.53M)(8.83M)(13.05M)
Capital Expenditures(69K)(84K)(33K)(25K)(60K)
Acquisitions (Net)00000
Purchases of Investments0(3.75M)(10.06M)(5.12M)(82.93M)
Sales of Investments3.27M012.06M6.68M10.6M
Other Investing Activities0(3K)3K00
Investing Cash Flow3.2M(3.84M)1.97M1.54M(72.38M)
Debt Repayment00000
Common Stock Issued04.32M6.56M7.94M86.24M
Common Stock Repurchased00000
Dividends Paid00000
Other Financing Activities00000
Financing Cash Flow04.32M6.56M7.94M86.24M
Effect of Forex Changes00000
Net Change in Cash(6.15M)(11.06M)(2K)646K810K
Free Cash Flow(9.42M)(11.63M)(8.57M)(8.85M)(13.11M)

Microbot Medical Inc.

NASDAQ:MBOT

Intrinsic Alpha fair value

Locked

Current Price

$0.98

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.